Embecta Corp. (EMBC)
(Delayed Data from NSDQ)
$14.34 USD
-0.83 (-5.47%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $14.34 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth C Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
For Embecta Corp., the company has a dividend yield of 3.96% compared to the Medical Services industry's median yield of zero percent.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
EMBC 14.34 -0.83(-5.47%)
Will EMBC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EMBC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EMBC
Best Income Stocks to Buy for September 15th
New Strong Buy Stocks for September 15th
EMBC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Value Stocks to Buy for September 9th
Embecta Corp. (EMBC) Crossed Above the 200-Day Moving Average: What That Means for Investors
Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here's What You Should Know
Other News for EMBC
Is EMBC gathering momentum? Bollinger Band Squeeze shows up after rising 0.73%
Analysts Have Conflicting Sentiments on These Healthcare Companies: Nektar Therapeutics (NKTR), Embecta Corporation (EMBC) and Replimune Group (REPL)
EMBC forms Shooting Star Candlestick on September 17
EMBC traded flat on September 16, leaving the technical picture intact
Embecta management to meet with BTIG